McKesson Corporation (LON:0JZU)
London
· Delayed Price · Currency is GBP · Price in USD | Market Cap | 74.91B |
| Revenue (ttm) | 287.97B |
| Net Income (ttm) | 3.00B |
| Shares Out | n/a |
| EPS (ttm) | 23.89 |
| PE Ratio | 24.97 |
| Forward PE | 19.82 |
| Dividend | 2.32 (0.29%) |
| Ex-Dividend Date | Dec 1, 2025 |
| Volume | 356 |
| Average Volume | 401 |
| Open | 816.74 |
| Previous Close | 810.60 |
| Day's Range | 800.00 - 818.64 |
| 52-Week Range | 558.25 - 899.40 |
| Beta | 0.39 |
| RSI | 40.84 |
| Earnings Date | Feb 4, 2026 |
About McKesson
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialt... [Read more]
Financial Performance
In 2024, McKesson's revenue was $359.05 billion, an increase of 16.22% compared to the previous year's $308.95 billion. Earnings were $3.30 billion, an increase of 9.76%.
Financial numbers in USD Financial StatementsNews
If You Invested $1000 In McKesson Stock 5 Years Ago, You Would Have This Much Today
McKesson (NYSE: MCK) has outperformed the market over the past 5 years by 21.85% on an annualized basis producing an average annual return of 34.98%. Currently, McKesson has a market capitalization o...
McKesson Corp at Evercore ISI Healthcare Conference Transcript
McKesson Corp at Evercore ISI Healthcare Conference Transcript
McKesson Corporation (MCK) Presents at Evercore 8th Annual Healthcare Conference Transcript
Guru Fundamental Report for MCK
Below is Validea's guru fundamental report for MCKESSON CORP (MCK). Of the 22 guru strategies we follow, MCK rates highest using our Multi-Factor Investor model based on the published strategy of Pim ...
Noteworthy ETF Outflows: USMV, MCK, COR, WM
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI USA Min Vol Factor ETF (Symbol: USMV) where we have detec...
McKesson's Advancing Community Oncology Report Charts a New Era of Innovation for Biopharma and Community Care
IRVING, Texas--(BUSINESS WIRE)--McKesson published its first-ever Advancing Community Oncology Report, a look at the trends influencing community oncology practices across the U.S.
Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now?
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
3 Reasons Growth Investors Will Love McKesson (MCK)
McKesson (MCK) could produce exceptional returns because of its solid growth attributes.
Is McKesson (MCK) a Buy as Wall Street Analysts Look Optimistic?
According to the average brokerage recommendation (ABR), one should invest in McKesson (MCK). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recomme...
Here's How Much $1000 Invested In McKesson 5 Years Ago Would Be Worth Today
McKesson (NYSE: MCK) has outperformed the market over the past 5 years by 24.3% on an annualized basis producing an average annual return of 36.95%. Currently, McKesson has a market capitalization of...
Noteworthy ETF Outflows: IWF, VRTX, BX, MCK
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 Growth ETF (Symbol: IWF) where we have detected a...
Final Trades: Freeport-McMoRan, Cisco, Teradyne and McKesson Corp.
The Investment Committee give you their top stocks to watch for the second half.
Final Trades: Freeport-McMoRan, Cisco, Teradyne and McKesson Corp.
The Investment Committee give you their top stocks to watch for the second half.
6 Healthcare Stocks With Strong Upward Momentum
Out with the old (tech), in with the new (healthcare). After several volatile weeks, it appears a full-fledged rotation has begun with investors fleeing previously high-flying tech winners in favor of...
Validea Detailed Fundamental Analysis - MCK
Below is Validea's guru fundamental report for MCKESSON CORP (MCK). Of the 22 guru strategies we follow, MCK rates highest using our Multi-Factor Investor model based on the published strategy of Pim ...
Our Top 10 High Growth Dividend Stocks - November 2025
The article provides a methodology for selecting high-growth dividend-paying stocks, focusing on dividend growth and sustainability rather than high current yield. We use our proprietary models to rat...
IWF, KO, VRTX, MCK: ETF Inflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 Growth ETF (Symbol: IWF) where we have detected a...
See Which Of The Latest 13F Filers Holds MCK
At Holdings Channel, we have reviewed the latest batch of the 31 most recent 13F filings for the 09/30/2025 reporting period, and noticed that McKesson Corp (Symbol: MCK) was held by 12 of these funds...
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Why McKesson (MCK) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
4 Value Stocks With Strong Interest Coverage as Markets Rebound
As Wall Street rebounds on hopes of a shutdown resolution, investors turn to value picks like LTH, CAH, MCK and FLS with strong interest coverage ratios.
McKesson Corporation (MCK) Presents at UBS Global Healthcare Conference 2025 Transcript
McKesson Corporation (MCK) UBS Global Healthcare Conference 2025 November 10, 2025 9:30 AM ESTCompany ParticipantsBritt Vitalone - Executive VP &...
McKesson (MCK) Price Target Raised by Wells Fargo; Rating Maintained | MCK Stock News
McKesson (MCK) Price Target Raised by Wells Fargo; Rating Maintained | MCK Stock News
Here is Why Growth Investors Should Buy McKesson (MCK) Now
McKesson (MCK) is well positioned to outperform the market, as it exhibits above-average growth in financials.
MCK Crosses Above Average Analyst Target
In recent trading, shares of McKesson Corp (Symbol: MCK) have crossed above the average analyst 12-month target price of $846.60, changing hands for $858.61/share. When a stock reaches the target an a...